All Pharma News
Aegerion`s Biologic Yyalipt (Metreleptin) Receives Approval in the U.S.

Aegerion`s Biologic Yyalipt (Metreleptin) Receives Approval in the U.S.
FDA
31 Mar 2023
Share Share
Aegerion`s Biologic Myalept (Metreleptin) Receives Approval in the U.S.

Aegerion`s Biologic Myalept (Metreleptin) Receives Approval in the U.S.
FDA
28 Feb 2022
Share Share
Aegerion`s Biological Metreleptin Receives Approval In US

Aegerion`s Biological Metreleptin Receives Approval In US
FDA
14 Jun 2021
Share Share
Aegerion`s Myalept ( Metreleptin) Receives Supplemental Approval in US

Aegerion`s Myalept ( Metreleptin) Receives Supplemental Approval in US
FDA
16 Jul 2020
Share Share
Amryt buys Aegerion via bankruptcy, adding sales to support R&D

Amryt buys Aegerion via bankruptcy, adding sales to support R&D
N.P.Taylor FIERCE BIOTECH
26 Sep 2019
Share Share
Coming out of Chapter 11, Aegerion jumps into welcome arms of Irish pharma

Coming out of Chapter 11, Aegerion jumps into welcome arms of Irish pharma
Amber Tong ENDPTS
25 Sep 2019
Share Share
The top 10 most-expensive meds in the U.S.—and they`re not the usual suspects

The top 10 most-expensive meds in the U.S.—and they`re not the usual suspects
Eric Sagonowsky FIERCE PHARMA
13 Jun 2019
Share Share
Amryt to expand rare disease portfolio with $311m Aegerion merger

Amryt to expand rare disease portfolio with $311m Aegerion merger
Richard Staines PHARMAPHORUM
23 May 2019
Share Share
Novelion`s Announces Subsidiary Aegerionto Recapitalize Court Supervised Process

Novelion`s Announces Subsidiary Aegerionto Recapitalize Court Supervised Process
NASDAQ
20 May 2019
Share Share
The 20 most expensive retail drugs in 2018

The 20 most expensive retail drugs in 2018
Eric Sagonowsky FIERCE PHARMA
29 Dec 2018
Share Share